Furthermore, silencing of FANCI resulted in significant downregulation of several FA complex members both at mRNA and protein levels, indicating the potential regulatory function of FANCI on the FA pathway in prostate cancer cells. The gene discussed is FANCA; the disease is prostate cancer.